Research
Semaglutide may lower fetal oxygen levels, sheep study suggests
The Brief
- A sheep study suggests semaglutide, the active ingredient in Ozempic and Wegovy, may lower fetal oxygen levels.
- The article notes these medications may also improve women's chances of becoming pregnant.
Why it matters
Semaglutide is widely used for weight loss, and the findings raise questions about its effects on unborn babies if women keep taking it during pregnancy. The available source is a short excerpt describing animal research.
Who’s affected
- women taking semaglutide who become or are pregnant
- clinicians prescribing semaglutide
- #semaglutide
- #pregnancy
- #fetal health
- #obesity drugs
- #animal study
They're the blockbuster drugs transforming weight loss, helping millions of people to shed unwanted kilograms. But while medications such as Ozempic and Wegovy may also improve women's chances of becoming pregnant, what happens to their unborn babies if they continue to take the…